pills2Founded in 1979, AmeriPharm is a privately held company that was created to bring a higher level of quality and service to contract and private-label manufacturing. Today, AmeriPharm serves some of the industry’s largest and most-respected customers around the world. At AmeriPharm we develop and manufacture high quality prescription, over-the counter and generic pharmaceutical products in solid and liquid dosage forms, that meet the current U.S. and international manufacturing standards. We also manufacture a wide array of dietary supplements and can provide you with many stock formulations that have a proven track record of success. AmeriPharm can also manufacture any type of custom vitamin and supplement formulations you may need. Nearly all of our vitamin and bulk supplements formulations are available in common industry forms including caplets, capsules, softgels, liquids, tablets, powders and creams.

about-usOur state-of-the-art, environmentally friendly facilities in Atlanta, Georgia and Reedsville, Pennsylvania, exceed cGMP standards and allow us to grow in anticipation of our customers’ needs. With over 400,000 square-feet of production and warehousing space, as well as continued expansion plans, AmeriPharm is equipped to bring your product vision to market.

For us, it is not just about making pharmaceuticals or supplements, it is about constantly driving to do things better than they have ever been done before in our industry. By being selective about the relationships we form and focusing on service, we build long-term partnerships throughout the supply chain. We believe our success is measured by our partners’ success, which is why we continuously support and protect the brands, franchises and consumers of our partners.

AmeriPharm is one of the nation’s premier custom supplement manufacturers for wholesale and bulk supplements, discount vitamins and liquid supplements. We are one of the leading liquid nutraceutical contract manufacturers and private label cGMP manufacturing companies in the USA. As such, we have one of our facilities that is a fully FDA approved OTC and Rx Pharmaceutical plant. Our other three plants are FDA and cGMP compliant for producing dietary supplements, in addition to being ASI certified. We make sure that when you order any of our vitamins and supplements that you get exactly what you ordered and that the ingredients match what is listed on our labels.

We were pioneers among American generic pharmaceutical companies to see tremendous value in investing in research & development (R&D). Our early investments in R&D, beginning three decades ago, enabled us to make technology our key differentiator and develop a basket of robust products for diverse markets across the world. Our core strength lies in our ability to excel in developing generics and technologically complex products through focused teams in formulations, process chemistry and analytical development. We have the capability to deliver quality products within established timelines, at low costs and without compromising on quality.

We have research scientists working in multiple R&D centers equipped with cutting-edge enabling technologies for research. Our scientists have expertise in developing generics, difficult to make technology intensive products, Active Pharmaceutical Ingredients (APIs), and Novel Drug Delivery Systems (NDDS). Our capabilities span the development of differentiated products, such as liposomal products, liquids, liquid capsules, soft gels, powders, RTDs, powders, rapid release solid dose forms, besides developing controlled release dosage forms.

Our knowledge in pharmaceutical and nutraceutical research allows a rapid ramp-up of a diverse range of immediate and Novel Delivery Systems spanning Oral Dosage Forms. Our formulation expertise lies in the areas of taste masking, spray-drying, drug-layering, micronizing or nano-milling, lyophilisation that enable us to cater to various formulation design needs and concepts. The ability to develop difficult-to-make, complex APIs and Nutraceuticals by using the latest technologies is the key differentiating factor of our research.

Our research capability has not only paid us rich dividends in terms of business, but also earned for us an enviable reputation for quality and capability. We have ensured world-class quality in design, equipment and operations in all our US manufacturing facilities. We have 4 ( Liquid, powder & finished dose) state-of-the-art manufacturing sites spanning 2 states. Our facilities ensure that we are able to provide best-in-class products to customers across 50 countries worldwide.

Our manufacturing operations are focused on producing generics, branded generics, speciality, over-the-counter (OTC) products and dietary supplements, in the full range of dosage forms, including tablets, capsules, powders, creams and liquids. We also manufacture specialty APIs, nutraceuticals, and botanical extracts for usage in our finished products. Our global Quality Management Team ensures that every product manufactured and distributed by us complies with all internationally accepted good practices and standards of quality, purity, efficacy and safety.


Over-The-Counter (OTC) Products

what-we-do2We offer a broad range of over-the-counter (OTC) products, including:

  • Dietary supplements
  • Pain Medication and NSAIDs
  • Cough & Cold pharmaceuticals
  • Powders
  • Liquids
  • Soft gels
  • Capsules
  • Tablets

Headquartered in Reedsville, Pa, AmeriPharm also has modern manufacturing plants in Atlanta encompassing a total of over 400,000 square feet and capacity to produce up to 3 Billion tablets, 1 Billion capsules, and 100 million soft gels a month.

By effectively manufacturing custom dosage formulations, AmeriPharm is the perfect partner for clients who choose to focus their attention on brand building and business development. The company’s solid-dose technicians fulfill clients tableting specifications while offering an array of unique delivery forms to choose from. Analytical method validation and release testing is accurately performed for feasibility and stability on clinical batches.

Comments are closed